Literature DB >> 17148533

Methods for handling missing data in palliative care research.

S Fielding1, P M Fayers, J H Loge, M S Jordhøy, S Kaasa.   

Abstract

Missing data is a common problem in palliative care research due to the special characteristics (deteriorating condition, fatigue and cachexia) of the population. Using data from a palliative study, we illustrate the problems that missing data can cause and show some approaches for dealing with it. Reasons for missing data and ways to deal with missing data (including complete case analysis, imputation and modelling procedures) are explored. Possible mechanisms behind the missing data are: missing completely at random, missing at random or missing not at random. In the example study, data are shown to be missing at random. Imputation of missing data is commonly used (including last value carried forward, regression procedures and simple mean). Imputation affects subsequent summary statistics and analyses, and can have a substantial impact on estimated group means and standard deviations. The choice of imputation method should be carried out with caution and the effects reported.

Entities:  

Mesh:

Year:  2006        PMID: 17148533     DOI: 10.1177/0269216306072555

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  5 in total

1.  Physical exercise for cancer patients with advanced disease: a randomized controlled trial.

Authors:  Line M Oldervoll; Jon H Loge; Stian Lydersen; Hanne Paltiel; May B Asp; Unni V Nygaard; Elisabeth Oredalen; Tone L Frantzen; Ingvild Lesteberg; Lise Amundsen; Marianne J Hjermstad; Dagny F Haugen; Ørnulf Paulsen; Stein Kaasa
Journal:  Oncologist       Date:  2011-09-26

2.  The Association of Perceived Social Support with Anxiety over Time in Parents of Children with Serious Illnesses.

Authors:  Jackelyn Y Boyden; Douglas L Hill; Karen W Carroll; Wynne E Morrison; Victoria A Miller; Chris Feudtner
Journal:  J Palliat Med       Date:  2019-11-07       Impact factor: 2.947

3.  Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17.

Authors:  B Cuer; C Mollevi; A Anota; E Charton; B Juzyna; T Conroy; C Touraine
Journal:  BMC Med Res Methodol       Date:  2020-09-03       Impact factor: 4.615

4.  Are the MORECare guidelines on reporting of attrition in palliative care research populations appropriate? A systematic review and meta-analysis of randomised controlled trials.

Authors:  Anna Oriani; Lesley Dunleavy; Paul Sharples; Guillermo Perez Algorta; Nancy J Preston
Journal:  BMC Palliat Care       Date:  2020-01-09       Impact factor: 3.234

5.  Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab.

Authors:  S Siena; M Peeters; E Van Cutsem; Y Humblet; P Conte; E Bajetta; D Comandini; G Bodoky; G Van Hazel; T Salek; M Wolf; G Devercelli; M Woolley; R G Amado
Journal:  Br J Cancer       Date:  2007-11-27       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.